In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Lewis Opler
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Lewis Opler

RESEARCHER INFORMATION
First Name:Lewis
Last Name:Opler
Title:Dr.
Advanced Degrees:MD, PhD
Affiliation:Columbia
Department:Psychiatry
Street Address 1:1051 Revierside Drive
City:New York
State/Province:NY
Zip/Postal Code:10032
Country/Territory:U.S.A.
Phone:9146291605
Fax:9146684814
Email Address:lao1@columbia.edu
Disclosure:
(view policy) 
Member reports the following financial or other potential conflicts of interest: [Last Modified: 14 June 2012]

As co-author of the PANSS, I receive royalties for sales of the PANSS Manual
View all comments by Lewis Opler
Clinical Interests:
Schizophrenia, posttraumatic stress disorder
Research Focus:
Pharmacology, GABAergic transmission, use of the PANSS, Phenomenology/diagnosis, Glutamatergic transmission
Work Sector(s):
Research institute, University, Private practice
Reasearcher Bio
Co-author of PANSS
Director of the Research Division of the NYS OMH from 1999-2010
Top Papers
Kay SR, Fiszbein A, Opler LA. Schizophrenia Bulletin, 1987
What are the top three papers (not yours) you have read recently?
Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, Minassian A, Becker O, Cooper J, Perry W, Lefebvre M, Gonzales J, Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry . 2010 Oct 1 ; 68(7):678-80.
If resources were not limited, what research projects would you pursue?
Treatment of cognition in schizophrenia
What is your leading hypothesis?
dysfunction in the NMDA-glutamate system
What piece of missing evidence would help prove it?
Ability to visualize through imaging
What is your fallback position?
Schizophrenia is heterogeneous: an umbrella for a number of different disorders



Research Participants
Collaborators
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright